Ischemic mitral regurgitation: current trends and treatment.Curr Opin Cardiol 2013; 28(6):661-5CO
PURPOSE OF REVIEW
Ischemic mitral regurgitation (MR) is a common finding in patients with coronary artery disease. In this review, we summarize the current literature describing the treatment of ischemic mitral regurgitation.
Recent publications have focused on describing outcomes following the treatment of ischemic mitral regurgitation based on the specific mechanism of regurgitation. New therapies such as remodeling rings and percutaneous approaches, along with insights into mitral valve replacement, have advanced the treatment of ischemic mitral regurgitation.
Mitral valve surgery and concomitant coronary artery bypass grafting represent the most effective strategy for the treatment of severe symptomatic ischemic mitral regurgitation. Overall, the survival of patients with ischemic mitral regurgitation is poor. Advances in mitral valve repair may improve long-term durability of surgery, whereas evolving percutaneous therapies may be a treatment option for patients with functional mitral regurgitation who are not surgical candidates.